プロスタグランジン

エポプロステノールナトリウム CAS 61849-14-7

お見積もり

エポプロステノールナトリウム CAS 61849-14-7

エポプロステノールナトリウム
61849-14-7

プロスタグランジン＆中間体

パッケージは1kg/袋から25kg/ドラムまでご要望に応じます。.

ご希望により、分子を変更可能（グラムからキロスケール）。.

製品名

エポプロステノールナトリウム

CAS番号.

61849-14-7

純度

NLT 99.0%

パッケージ

パッケージは1kg/袋から25kg/ドラムまでご要望に応じます。.

分子式

C20H31NaO5

分子量

374.4

スマイル

CCCCC[C@@H](/C=C/[C@H]1[C@@H](C[C@H]2[C@@H]1C/C(=C/CCCC(=O)[O-])/O2)O)O.[Na+]

IUPAC名

sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate

同義語

Epoprostenol sodium; 61849-14-7; Cyclo-Prostin; Sodium prostacyclin; Prostacyclin sodium salt; 4K04IQ1OF4; DTXSID3046617; U-53217A; U-53,217A; DTXCID1026617; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt, (5Z,9alpha,11alpha,13E,15S)-; RefChem:57240; 263-273-7; Sodium(Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; Flolan; Prostacyclin sodium; C20H31NaO5; sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate; Epoprostenol sodium [USAN:BAN]; NCGC00167427-01; EINECS 263-273-7; UNII-4K04IQ1OF4; U 53,217A; Epoprostenolsodium; (5Z,9?,11?,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt; Epoprostenol Sodium; Flolan;; Prostaglandin X sodium; PROSTAGLANDIN I2 Na; CHEMBL962; Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate; SCHEMBL41344; Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate; BML1-F10; orb1707331; EX-A7849M; EPOPROSTENOL SODIUM [JAN]; 4UA76; EPOPROSTENOL SODIUM [USAN]; HMS1361K18; HMS3648L14; EPOPROSTENOL SODIUM [VANDF]; EPOPROSTENOL SODIUM [MART.]; Tox21_112431; EPOPROSTENOL SODIUM [USP-RS]; EPOPROSTENOL SODIUM [WHO-DD]; PROSTACYCLIN SODIUM SALT [MI]; AKOS024457370; FP27241; EPOPROSTENOL SODIUM [ORANGE BOOK]; AC-38149; CAS-61849-14-7; NS00074283; Q27259818; (5Z,9a,11a,13E,15S)-6,9-epoxy-11,15-dihydroxy-prosta-5,13-dien-1-oic acid sodium;Epoprostenol sodium;Flolan; PROSTA-5,13-DIEN-1-OIC ACID, 6,9-EPOXY-11,15-DIHYDROXY-, SODIUM SALT, (5Z,9.ALPHA.,11.ALPHA.,13E,15S)-; SODIUM (Z)-(3AR,4R,5R,6AS)-HEXAHYDRO-5-HYDROXY-4-((E)-(3S)-3-HYDROXY-1-OCTENYL)-2H-CYCLOPENTA(B)FURAN-.DELTA.(SUP 2,.DELTA.)-VALERATE; Sodium (Z)-5-((3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxyoct-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-ylidene)pentanoate; epoprostenol; Veletri; prostacyclin; prostaglandin I2; Floran; Epoprosterol sodium; Prostaglandin I2 sodium; AC1O4BXH; C20H31O5.Na; C20H32O5.Na; LMHIPJMTZHDKEW-XQYLJSSYSA-M; ACT-385781A; C20-H31-Na-O5; MFCD00135629; 3-(4-methylphenyl)prop-2-enenitrile; CID5282410; CID6364626; LS-176206; 2641S; FT-0630728; V0155; A833449; 35121-78-9; Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer; (5Z,13E,8R,9S,11R,12R,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt; (5Z,9|A,11|A,13E,15S)-6,9-epoxy-11,15-Dihydroxy-prosta-5,13-dien-1-oic Acid Sodium Salt; 35121-93-8; Prosta-5,13-dien-1-oic acid, 6,9-epoxy-11,15-dihydroxy-, sodium salt (1:1), (5Z,9alpha,11alpha,13E,15S)-; sodium (5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate